Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Emory University issued U.S. patent for FTC compound

Oct. 7, 1998

New treatment for CMV retinitis in the pipeline at Roche

Oct. 7, 1998

Potent, orally absorbed HIV-1 protease inhibitors selected from series of azadipeptides

Oct. 6, 1998

The PAF antagonist MFH-1 shows potential as an adjunct in the therapy of AIDS

Oct. 6, 1998

New lead anti-HIV compound discovered by Italian university researchers

Oct. 6, 1998

U.S. is country of first launch for DuPont's NNRTI

Oct. 5, 1998

Sarawak MediChem initiates phase Ib trial of (+)-calanolide A

Oct. 2, 1998

Twice-daily Viracept as safe and effective as the approved t.i.d. schedule

Oct. 1, 1998

New azapeptide HIV protease inhibitor profiled at ICAAC

Sep. 30, 1998

Novel AIDS therapeutic enters phase I/II testing in South Africa

Sep. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...